IS-10 MDM2 SNP309 polymorphisms and the risk of gynecological cancer(Group1 Oncology1,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-02-01
著者
-
Ueda Masatsugu
Cytopathology and Gynecology, Osaka Cancer Prevention and Detection Center
-
Sato Naomi
Cytopathology and Gynecology, Osaka Cancer Prevention and Detection Center
-
Izuma Shinji
Cytopathology and Gynecology, Osaka Cancer Prevention and Detection Center
-
Okamoto Yoshiaki
Cytopathology and Gynecology, Osaka Cancer Prevention and Detection Center
-
Noda Sadamu
Cytopathology and Gynecology, Osaka Cancer Prevention and Detection Center
-
Sato Naomi
Cytopathology And Gynecology Osaka Cancer Prevention And Detection Center
-
Noda Sadamu
Cytopathology And Gynecology Osaka Cancer Prevention And Detection Center
-
Izuma Shinji
Cytopathology And Gynecology Osaka Cancer Prevention And Detection Center
-
Ueda Masatsugu
Cytopathology And Gynecology Osaka Cancer Prevention And Detection Center
-
Okamoto Yoshiaki
Cytopathology And Gynecology Osaka Cancer Prevention And Detection Center
関連論文
- IS-10 MDM2 SNP309 polymorphisms and the risk of gynecological cancer(Group1 Oncology1,International Session)
- P1-IS-1 Transcriptional expression of survivin and its splice variants in cervical carcinomas
- P1-IS-11 Clinical efficacy of conservative laser therapy for early stage cervical cancer
- P-IS-3 Diagnostic and therapeutic laser conization for cervical intraepithelial neoplasia(Oncology 1,Group 88,International Session)
- IS-54 Germline polymorphism of cancer susceptibility genes in gynecological cancer(Group6 Oncology3,International Session)